Skip to main content

Table 1 Mean and standard deviation of PVF and VI in % dog weight (N/N and N.s/N, respectively) applied on the diseased leg

From: Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs

Day 0 30 90 180
PVF ML 43.56 ± 0.73 49.21 ± 2.1 49.05 ± 1.51 53.2 ± 4.43
PVF LL 55.98 ± 0.62 53.96 ± 1.46 52.67 ± 1.91 51.53 ± 2.79
PVF S 47.40 ±1.43 47.74 ± 1.34 47.95 ±1.35 47.94 ± 1.65
VI ML 12.16 ± 0.72 13.75 ±1.17 13.71 ± 1.1 14.84 ± 1.29
VI LL 16.09 ± 1.01 15.51 ± 1.28 15.12 ± 1.45 14.83 ± 1.54
VI S 14.51 ± 0.47 14.62 ± 0.41 14.67 ± 0.42 14.67 ± 0.51
  1. PVF ML: peak vertical force in the more-lame limbs. PVF LL: peak vertical force in the less-lame limbs. VI ML: vertical impulse in the more-lame limbs VI LL: vertical impulse in the less-lame limbs. PVF S: peak vertical force in the control group. VI S: vertical impulse in the control group.
  2. Data are shown for each day of observation.